Cargando…
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation
Little is known about the signaling network responsible for the organization of the perinuclear actin cap, a recently identified structure holding unique roles in the regulation of nuclear shape and cell directionality. In cancer cells expressing a constitutively active MET, we show a rearrangement...
Autores principales: | Sgarzi, Michela, Mazzeschi, Martina, Santi, Spartaco, Montacci, Elisa, Panciera, Tito, Ferlizza, Enea, Girone, Cinzia, Morselli, Alessandra, Gelfo, Valerio, Kuhre, Rikke Sofie, Cavallo, Carola, Valente, Sabrina, Pasquinelli, Gianandrea, Győrffy, Balazs, D’Uva, Gabriele, Romaniello, Donatella, Lauriola, Mattia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576810/ https://www.ncbi.nlm.nih.gov/pubmed/37838732 http://dx.doi.org/10.1038/s42003-023-05411-y |
Ejemplares similares
-
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
por: Ferlizza, Enea, et al.
Publicado: (2023) -
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization
por: Romaniello, Donatella, et al.
Publicado: (2022) -
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer
por: Mazzeschi, Martina, et al.
Publicado: (2022) -
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy
por: Romaniello, Donatella, et al.
Publicado: (2023) -
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy
por: Gelfo, Valerio, et al.
Publicado: (2018)